RHD Genotyping

Test description

This is a PCR-based assay for the identification of many clinically significant RHD variants (alleles) responsible for normal and altered/absent expressions of the RhD human red cell antigen. This test is used to provide the predicted RhD status of a patient when it cannot be determined due to discrepant, weak or inconclusive serological RhD testing.

RHD Genotyping (PDF)

Test Catalogue

Locate a test

Specimen and requisition requirements

Specimen(s):

One (1) 2-7 ml EDTA (lavender) tube mixed thoroughly by gentle agitation.
Label specimen with the required minimum information: patient’s last name, first name, middle name, PHN or unique identifier and date of collection.

Complete Requisition (must include):

Patient’s last name, first name, middle name, PHN or unique identifier and date of birth
Facility name, complete address, phone and fax number
Phlebotomist ID information
Date of collection

Requisition(s)

Request for RHD Genotyping (PDF)
(Electronic Fillable Form)

RHD Genotyping (Frequently Asked Questions) (PDF)

Information Regarding Limited Availability of RHD Genotyping Kits (PDF)

Demande de génotypage RhD (PDF)
(Peut être rempli en ligne)

Pre-shipping storage

Recommended Refrigeration 1-10°C

Shipping instructions

Submit samples as soon as possible after collection.

Shipping
Ship in a container that will maintain temperature 2°C to 25°C
Select shipping method for container to arrive at testing site within 48 hours.
Sample must be received at testing site within 14 days of collection.

Note: Protect from freezing.

Send to

Canadian Blood Services
National Immunohematology Reference Laboratory (NIRL)
100 Parkshore Drive
Brampton, ON, L6T 5M1
Tel: 905-494-5295
Fax: 905-494- 8131